|
MEP42108A
(en)
|
1998-10-23 |
2011-02-10 |
Kiren Amgen Inc |
Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
US7320789B2
(en)
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
BR0307871A
(pt)
|
2002-02-21 |
2005-04-12 |
Wyeth Corp |
Proteìnas contendo domìnio de folistatina
|
|
EP1572909A4
(en)
|
2002-02-21 |
2007-06-06 |
Wyeth Corp |
PROTEIN CONTAINING A DOMAINE OF FOLLISTATIN
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
MXPA05002968A
(es)
*
|
2002-09-16 |
2005-09-08 |
Univ Johns Hopkins |
Activacion de miostatina por metaloproteasa, y metodos de modular la actividad de miostatina.
|
|
AR047392A1
(es)
|
2002-10-22 |
2006-01-18 |
Wyeth Corp |
Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
|
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
|
BR0317538A
(pt)
*
|
2002-12-20 |
2005-11-29 |
Amgen Inc |
Agente ligante, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, e, métodos de inibir a atividade de miostatina, de aumentar a massa muscular magra e a razão de massa muscular magra para gordura, de tratar uma doença de emaciação muscular e um distúrbio metabólico relacionado com miostatina em um indivìduo, de detectar e medir miostatina em uma amostra, e, de diagnosticar um distúrbio relacionado com miostatina em um indivìduo
|
|
RU2322261C2
(ru)
*
|
2003-06-02 |
2008-04-20 |
Уайт |
Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
ES2383300T3
(es)
*
|
2003-11-13 |
2012-06-20 |
Hanmi Holdings Co., Ltd |
Fragmento Fc de IgG para un vehículo de fármacos y procedimiento para su preparación
|
|
EP1699820A2
(en)
|
2003-12-31 |
2006-09-13 |
Schering-Plough Ltd. |
Neutralizing epitope-based growth enhancing vaccine
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
JP2008500373A
(ja)
*
|
2004-05-27 |
2008-01-10 |
アクセルロン ファーマ インコーポレーテッド |
ケルベロス（Ｃｅｒｂｅｒｕｓ）／ココ（Ｃｏｃｏ）誘導体およびそれらの使用
|
|
US8143380B2
(en)
*
|
2004-07-08 |
2012-03-27 |
Amgen Inc. |
Therapeutic peptides
|
|
WO2006036834A2
(en)
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
CA2594276A1
(en)
|
2004-12-30 |
2006-07-13 |
Schering-Plough Ltd. |
Neutralizing epitope-based growth enhancing vaccine
|
|
NZ538097A
(en)
*
|
2005-02-07 |
2006-07-28 |
Ovita Ltd |
Method and compositions for improving wound healing
|
|
JP2008537777A
(ja)
*
|
2005-03-23 |
2008-09-25 |
ワイス |
Ｇｄｆ−８調節剤に対する免疫応答の検出
|
|
EP1864138A2
(en)
*
|
2005-03-23 |
2007-12-12 |
Wyeth |
Detection of gdf-8 modulating agents
|
|
BRPI0611901A2
(pt)
|
2005-06-14 |
2012-08-28 |
Amgen, Inc |
composição, liofilizado, kit, e, processo para preparar uma composição
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
EP1951756B1
(en)
*
|
2005-10-06 |
2015-01-07 |
Eli Lilly And Company |
Anti-myostatin antibodies
|
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
|
US20090163579A1
(en)
*
|
2005-10-14 |
2009-06-25 |
Daniel Raederstorff |
Novel use of nutraceutical compositions
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
WO2007067616A2
(en)
*
|
2005-12-06 |
2007-06-14 |
Amgen Inc |
Uses of myostatin antagonists
|
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
|
BRPI0716249A2
(pt)
|
2006-09-05 |
2013-09-03 |
Lilly Co Eli |
anticorpos antimiostatina
|
|
WO2008051383A2
(en)
*
|
2006-10-19 |
2008-05-02 |
Amgen Inc. |
Use of alcohol co-solvents to improve pegylation reaction yields
|
|
CA2671983A1
(en)
*
|
2006-12-08 |
2009-06-19 |
Acceleron Pharma Inc. |
Uses of cerberus, coco and derivatives thereof
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
US7947646B2
(en)
|
2007-03-06 |
2011-05-24 |
Amgen Inc. |
Variant activin receptor polypeptides
|
|
EP2162540A2
(en)
|
2007-05-22 |
2010-03-17 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
WO2009015345A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Amgen Inc. |
Pharmaceutical compositions comprising fc fusion proteins
|
|
CA2685540C
(en)
|
2007-08-03 |
2018-10-16 |
Graham Michael Wynne |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
MX2010002249A
(es)
*
|
2007-08-31 |
2010-03-17 |
Amgen Inc |
Formulacion de proteina de estado solido.
|
|
EP2205280B1
(en)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmaceutical formulations
|
|
US8796206B2
(en)
|
2007-11-15 |
2014-08-05 |
Amgen Inc. |
Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
|
|
CA2723987C
(en)
|
2008-05-14 |
2019-06-11 |
Agriculture Victoria Services Pty Ltd |
Use of angiogenin or angiogenin agonists for treating diseases and disorders
|
|
JP5611222B2
(ja)
|
2008-11-26 |
2014-10-22 |
アムジエン・インコーポレーテツド |
アクチビンｉｉｂ受容体ポリペプチドの変異体及びその使用
|
|
EP3366692A1
(en)
|
2009-06-22 |
2018-08-29 |
Amgen, Inc |
Refolding proteins using a chemically controlled redox state
|
|
AU2010266093B2
(en)
|
2009-06-25 |
2013-06-27 |
Amgen Inc. |
Capture purification processes for proteins expressed in a non-mammalian system
|
|
US8945511B2
(en)
*
|
2009-06-25 |
2015-02-03 |
Paul Weinberger |
Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
|
|
WO2011050333A1
(en)
|
2009-10-23 |
2011-04-28 |
Amgen Inc. |
Vial adapter and system
|
|
JO3340B1
(ar)
*
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
SG186094A1
(en)
|
2010-06-07 |
2013-01-30 |
Amgen Inc |
Drug delivery device
|
|
SG187867A1
(en)
|
2010-08-16 |
2013-03-28 |
Amgen Inc |
Antibodies that bind myostatin, compositions and methods
|
|
AU2012236573B2
(en)
|
2011-03-31 |
2016-06-02 |
Amgen Inc. |
Vial adapter and system
|
|
HUE042822T2
(hu)
|
2011-04-20 |
2019-07-29 |
Amgen Inc |
Automata befecskendezõ szerkezet
|
|
WO2012153337A2
(en)
*
|
2011-05-11 |
2012-11-15 |
Technion Research & Development Foundation Ltd. |
Anti-microbial peptides and uses of same
|
|
PL3045187T3
(pl)
|
2011-10-14 |
2019-09-30 |
Amgen Inc. |
Wstrzykiwacz i sposób montażu
|
|
EA201992617A1
(ru)
|
2011-10-26 |
2020-03-10 |
Амген Инк. |
Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения
|
|
FR2982860B1
(fr)
*
|
2011-11-18 |
2015-07-10 |
Ass Fr Contre Les Myopathies |
Utilisation de la fibromoduline et du lumican pour augmenter la masse musculaire
|
|
HK1203384A1
(en)
|
2011-12-19 |
2015-12-11 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
RU2634407C2
(ru)
|
2012-03-26 |
2017-10-26 |
Эксселла Хелт Инк. |
Фрагменты пищевых белков и способы их применения
|
|
EP2831100A4
(en)
|
2012-03-26 |
2016-02-10 |
Pronutria Inc |
NUTRIENT PROTEINS AND METHOD
|
|
EP2831098A4
(en)
|
2012-03-26 |
2016-12-07 |
Axcella Health Inc |
LOADED NUTRIENT PROTEINS AND METHODS
|
|
US9700071B2
(en)
|
2012-03-26 |
2017-07-11 |
Axcella Health Inc. |
Nutritive fragments, proteins and methods
|
|
AU2013204740C1
(en)
|
2012-05-10 |
2015-10-01 |
Agriculture Victoria Services Pty Ltd |
Methods of treating cancer using angiogenin or an angiogenin agonist
|
|
US9873739B2
(en)
|
2012-08-01 |
2018-01-23 |
Ikaika Therapeutics, Llc |
Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4)
|
|
ES2860954T3
(es)
|
2012-11-21 |
2021-10-05 |
Amgen Inc |
Dispositivo de administración de fármacos
|
|
WO2014119753A1
(ja)
*
|
2013-01-31 |
2014-08-07 |
学校法人 東京薬科大学 |
マイオスタチン阻害ペプチド
|
|
AU2014212014A1
(en)
|
2013-02-01 |
2015-08-27 |
Amgen Inc. |
Administration of an anti-activin-A compound to a subject
|
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
|
US10646664B2
(en)
|
2013-03-15 |
2020-05-12 |
Amgen Inc. |
Body contour adaptable autoinjector device
|
|
TWI614041B
(zh)
|
2013-03-15 |
2018-02-11 |
安美基公司 |
用於注射器之匣盒
|
|
WO2014149357A1
(en)
|
2013-03-22 |
2014-09-25 |
Amgen Inc. |
Injector and method of assembly
|
|
KR101523065B1
(ko)
*
|
2013-06-19 |
2015-05-27 |
한국기초과학지원연구원 |
입자크기가 제어된 금 나노입자의 제조방법 및 제조된 금 나노입자를 이용한 비색식 강산 검출방법
|
|
TW201601741A
(zh)
*
|
2013-09-09 |
2016-01-16 |
品特生物療法有限公司 |
用於治療ｅｓｒｄ病患之ｐｅｗ的肌肉生長抑制素拮抗劑
|
|
RU2016110800A
(ru)
|
2013-09-25 |
2017-10-30 |
Пронутриа Биосайенсис, Инк. |
Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
|
|
CA3168888A1
(en)
|
2013-10-24 |
2015-04-30 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
|
SG11201602876WA
(en)
|
2013-10-24 |
2016-05-30 |
Amgen Inc |
Injector and method of assembly
|
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
AU2015256082C1
(en)
|
2014-05-07 |
2020-09-10 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
|
CN111840696B
(zh)
|
2014-06-03 |
2022-12-20 |
安姆根有限公司 |
可控制药物递送系统和使用方法
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
EP3206739B1
(en)
|
2014-10-14 |
2021-12-01 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
EP3215175A4
(en)
|
2014-11-06 |
2018-06-27 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
|
EP3848072A1
(en)
|
2014-12-19 |
2021-07-14 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
JP6484345B2
(ja)
|
2015-02-17 |
2019-03-20 |
アムジエン・インコーポレーテツド |
固定及び／または戻りが真空によって支援された薬物送達装置
|
|
WO2016138434A1
(en)
|
2015-02-27 |
2016-09-01 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
ES2856936T3
(es)
|
2015-04-23 |
2021-09-28 |
Univ Washington State |
Suministro del gen Smad7 como un agente terapéutico
|
|
CN106191215B
(zh)
|
2015-04-29 |
2020-03-24 |
中国科学院上海生命科学研究院 |
肌肉萎缩相关的蛋白质分子标记Dkk-3的筛选及其应用
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
DK3334747T5
(da)
|
2015-08-13 |
2024-10-07 |
Amgen Inc |
Ladet dybdefiltrering af antigenbindende proteiner
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
HRP20211081T1
(hr)
|
2015-09-15 |
2021-10-15 |
Scholar Rock, Inc. |
Anti-pro/latentna miostatinska protutijela i njihove uporabe
|
|
JP7082568B2
(ja)
|
2015-12-09 |
2022-06-08 |
アムジエン・インコーポレーテツド |
信号伝達キャップ付き自動注射器
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
CN115814077A
(zh)
|
2016-01-08 |
2023-03-21 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其使用方法
|
|
DK3429663T3
(da)
|
2016-03-15 |
2020-09-28 |
Amgen Inc |
Reduktion af sandsynligheden for glasbrud i anordninger til indgivelse af lægemidler
|
|
RU2613420C1
(ru)
*
|
2016-04-13 |
2017-03-16 |
Сергей Михайлович Юдин |
Рекомбинантный белок Мио-ГСД, способ его получения, инъекционный препарат для повышения мышечной массы сельскохозяйственных животных, птицы и животных семейства псовых, а также способ использования препарата
|
|
ES2981471T3
(es)
*
|
2016-04-25 |
2024-10-09 |
Five Prime Therapeutics Inc |
NOPE para el tratamiento de la pérdida de masa muscular y la debilidad muscular patológicas
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US10150115B2
(en)
*
|
2016-07-21 |
2018-12-11 |
Spacepharma SA |
System and method for rehydrating powder and delivering the rehydrated powder to a reactor
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
PT3528787T
(pt)
|
2016-10-21 |
2026-03-11 |
Amgen Inc |
Formulações farmacêuticas e métodos para produzir as mesmas
|
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
EP4218817A3
(en)
*
|
2017-01-06 |
2023-09-06 |
Scholar Rock, Inc. |
Methods for treating metabolic diseases by inhibiting myostatin activation
|
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
WO2018151890A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
CA3052204A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
EP3592403B1
(en)
|
2017-03-06 |
2025-08-20 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
US11571511B2
(en)
|
2017-03-07 |
2023-02-07 |
Amgen Inc. |
Insertion mechanism and method of inserting a needle of a drug delivery device
|
|
AU2018230486B2
(en)
|
2017-03-09 |
2023-05-11 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
ES3023742T3
(en)
|
2017-03-28 |
2025-06-03 |
Amgen Inc |
Plunger rod and syringe assembly system
|
|
US11590294B2
(en)
|
2017-06-08 |
2023-02-28 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
JP7200134B2
(ja)
|
2017-06-08 |
2023-01-06 |
アムジエン・インコーポレーテツド |
トルク駆動式薬物送達デバイス
|
|
JP7195276B2
(ja)
|
2017-06-22 |
2022-12-23 |
アムジエン・インコーポレーテツド |
デバイス起動による衝突／衝撃の低減
|
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
|
IL270784B2
(en)
|
2017-07-14 |
2023-11-01 |
Amgen Inc |
Needle insertion-extraction system with a double torsion spring system
|
|
JP7649105B2
(ja)
|
2017-07-21 |
2025-03-19 |
アムジエン・インコーポレーテツド |
薬物容器のためのガス透過性シーリング部材及び組立方法
|
|
MA49676A
(fr)
|
2017-07-25 |
2020-06-03 |
Amgen Inc |
Dispositif d'administration de médicament doté d'un système d'accès à un récipient et procédé d'assemblage associé
|
|
US11617837B2
(en)
|
2017-07-25 |
2023-04-04 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
EP3668567B1
(en)
|
2017-08-18 |
2026-02-18 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
|
ES2971450T3
(es)
|
2017-10-06 |
2024-06-05 |
Amgen Inc |
Dispositivo de administración de fármacos con conjunto de enclavamiento y procedimiento de montaje correspondiente
|
|
US11464903B2
(en)
|
2017-10-09 |
2022-10-11 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
|
IL273582B2
(en)
|
2017-11-03 |
2024-12-01 |
Amgen Inc |
Systems and approaches for sterilizing a drug delivery device
|
|
EP3706830B1
(en)
|
2017-11-06 |
2024-08-07 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
EP3707075A1
(en)
|
2017-11-06 |
2020-09-16 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
MA50557A
(fr)
|
2017-11-10 |
2020-09-16 |
Amgen Inc |
Pistons pour dispositifs d'administration de médicament
|
|
JP7370969B2
(ja)
|
2017-11-16 |
2023-10-30 |
アムジエン・インコーポレーテツド |
薬物送達デバイスの扉ラッチ機構
|
|
MX2020005066A
(es)
|
2017-11-16 |
2020-08-20 |
Amgen Inc |
Autoinyector con deteccion de detencion y punto final.
|
|
EP3569614A1
(en)
|
2018-05-18 |
2019-11-20 |
Julius-Maximilians-Universität Würzburg |
Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
KR102042352B1
(ko)
|
2018-07-16 |
2019-11-07 |
강릉원주대학교산학협력단 |
땅콩 껍질 추출물을 포함하는 근력강화 또는 근감소증의 예방 및 치료용 조성물
|
|
KR102259645B1
(ko)
|
2018-07-16 |
2021-06-02 |
강릉원주대학교산학협력단 |
구멍쇠미역 추출물을 포함하는 근력강화 또는 근감소증의 예방 및 치료용 조성물
|
|
CA3103681A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
MA53375A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
CA3110371A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
EP3860685A1
(en)
|
2018-10-02 |
2021-08-11 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
US12151089B2
(en)
|
2018-10-05 |
2024-11-26 |
Amgen Inc. |
Drug delivery device having dose indicator
|
|
TW202541859A
(zh)
|
2018-10-15 |
2025-11-01 |
美商安進公司 |
具有阻尼機構之藥物遞送裝置及自動注射器
|
|
WO2020081480A1
(en)
|
2018-10-15 |
2020-04-23 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
|
MX2021004510A
(es)
|
2018-10-23 |
2021-06-08 |
Amgen Inc |
Calibracion automatica y mantenimiento automatico de modelos espectroscopicos de raman para predicciones en tiempo real.
|
|
EP3873563A1
(en)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
MA54048A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament
|
|
WO2020132647A1
(en)
|
2018-12-21 |
2020-06-25 |
Northwestern University |
Use of annexins in preventing and treating muscle membrane injury
|
|
WO2020139977A1
(en)
|
2018-12-26 |
2020-07-02 |
Northwestern University |
Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder
|
|
AU2020263289B2
(en)
|
2019-04-24 |
2025-05-22 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
WO2021041067A2
(en)
|
2019-08-23 |
2021-03-04 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
WO2021158469A1
(en)
|
2020-02-03 |
2021-08-12 |
Amgen Inc. |
Multivariate bracketing approach for sterile filter validation
|
|
JP2024523779A
(ja)
|
2021-05-21 |
2024-07-02 |
アムジェン インコーポレイテッド |
薬物容器用の充填レシピを最適化する方法
|
|
JP2025500732A
(ja)
|
2021-10-27 |
2025-01-15 |
アムジエン・インコーポレーテツド |
分光法を使用して薬剤を監視するための深層学習ベースの予測
|
|
WO2023096232A1
(ko)
*
|
2021-11-25 |
2023-06-01 |
(주)네오크레마 |
신규 펩티드 및 이의 용도
|
|
US20250082720A1
(en)
*
|
2021-11-25 |
2025-03-13 |
Neo Cremar Co., Ltd. |
New peptide and uses thereof
|
|
KR102726402B1
(ko)
*
|
2021-11-25 |
2024-11-05 |
(주)네오크레마 |
지방전구세포의 증식과 지방세포로의 분화를 억제하는 신규 펩티드 및 이의 용도
|
|
KR102726401B1
(ko)
*
|
2021-11-25 |
2024-11-05 |
(주)네오크레마 |
지방전구세포의 증식과 지방세포로의 분화를 억제하는 신규 펩티드 및 이의 용도
|
|
CN115403657A
(zh)
*
|
2022-06-23 |
2022-11-29 |
浙江大学 |
一种TGF-β3生长因子的亲和多肽及其应用
|
|
EP4638496A1
(en)
|
2022-12-22 |
2025-10-29 |
Scholar Rock, Inc. |
Selective and potent inhibitory antibodies of myostatin activation
|
|
WO2025037108A2
(en)
|
2023-08-15 |
2025-02-20 |
Board Of Trustees Of The Leland Stanford Junior University |
Modified thrombopoietin
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|